<DOC>
	<DOCNO>NCT00469612</DOCNO>
	<brief_summary>The purpose present study carry trial evaluate clinical efficacy NeuroVision Low Myopia Treatment . The specific question answer : 1 . Is improvement vision follow treatment without bring change subject 's prescription glass ? 2 . Can treatment effect see 6 month 12 month termination treatment ?</brief_summary>
	<brief_title>Evaluating NeuroVision 's Neural Vision Correction ( NVC ) Myopia Treatment</brief_title>
	<detailed_description>Myopia treatment modality one widely study area vision research . So far treatment option optical i.e. , patient myopia either correct spectacle , contact lens refractive surgery provide clear vision . NeuroVision 's NVC vision correction technology novel method treatment low myopia technology direct specific neuronal interaction level visual cortex ( area responsible vision brain ) . It use non-invasive , patient-specific treatment purport improve neuronal efficiency induce improvement overall ability see due reduction noise increase signal strength . As visual perception quality depend input receive eye process visual cortex , NeuroVision 's technology hypothesize compensate blur ( myopic ) input , enhance neural processing . We conduct clinical evaluation effectiveness system . The subject expose set visual stimulation ( pattern black white line ) visual threshold level obtain . The subject look pattern computer . The treatment apply successive 30-40 minute session , administer 2-3 time week , total 40 session . Every 5 session , subject 's visual performance ( visual acuity , ability see letter vary size , CSF , ability see black white line vary contrast ) test order continuously monitor subject 's progress . At end session , data send NeuroVision Web Server . Proprietary algorithmic software analyze patient 's performance progress generate parameter next treatment session . The purpose study assess effect correct uncorrected visual performance follow treatment .</detailed_description>
	<mesh_term>Myopia</mesh_term>
	<criteria>Age 18 59 year Spherical equivalent bad eye exceed 1.5 DS astigmatism exceed 0.75 DC . The subject 's refractive status stable , increase beyond 0.5D sphere cylinder last six month . That , subject 's spectacle prescription differ autorefraction value 0.50D . Unaided visual acuity 0.6 LogMAR good eye poorer unaided acuity Unaided visual acuity 0.1 LogMAR bad eye well unaided acuity Unaided visual acuity difference eye less 0.3 LogMAR Bestcorrected visual acuity 0.04 LogMAR good eye . The subject aware study follow feature : 1 . The recommended pace treatment session least 3 session per week . 2 . Interruptions longer 2 week treatment course . Note : The subject free voluntarily withdraw study time . The subject suffers visually disable eye disease ( ) cause reduced visual acuity , aside myopia and/or astigmatism The subject suffers myopiarelated visual complication result visual loss , include myopic macular degeneration , myopic cataract previous preexist myopic retinal detachment . The subject suffering Diabetes Mellitus . The subject suffers Migraines The subject suffers Epilepsy The subject pregnant . ( It recommend include pregnant woman expect visual fluctuation . The NV treatment , basically use computer , impact pregnancy . ) No pregnancy test do identified verbal history . The study use tropicamide drug ( dilation drop ) proparacaine ( topical anesthetic ) , routinely use eye drop everyday clinical practice adverse effect report far pregnant woman fetus . The subject activity limitation due medical disorder ( include migraine , seizure disorder , etc . ) , medication , emotional status might potentially impair subject 's ability perform treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Myopia</keyword>
	<keyword>NeuroVision</keyword>
	<keyword>Visual acuity</keyword>
	<keyword>Contrast sensitivity</keyword>
</DOC>